Volume 16, Number 11—November 2010
Research
Comparison of 3 Infrared Thermal Detection Systems and Self-Report for Mass Fever Screening
Table 1
Characteristics | OptoTherm, n = 2,507 patients | FLIR, n = 2,515 patients | Wahl, n = 2,061 patients | Self-reported fever, n = 2,389 patients |
---|---|---|---|---|
Mean temperature, °F (SD) | 94.3 (1.26) | 95.7 (1.38) | 89.4 (2.56) | – |
Optimal fever threshold, °F |
95.3 |
96.4 |
89.3 |
– |
Fever (oral temperature >100°F) | ||||
No. (%) identified as febrile by each method | 275 (11.0) | 247 (9.8) | 577 (28.0) | 404 (16.9) |
Sensitivity (95% CI) | 91.0 (85.0–97.0) | 90.0 (84.0–97.0) | 80.0 (76.0–85.0) | 75.0 (64.4–85.6) |
Specificity (95% CI) | 86.0 (81.0–90.0) | 80.0 (76.0–84.0) | 65.0 (61.0–69.0) | 84.7 (83.4–86.1) |
Positive predictive value (95% C) | 17.9 (13.6–22.2) | 18.4 (13.7–23.0) | 5.7 (4.1–7.3) | 10.1 (7.4–12.8) |
Negative predictive value (95% CI) |
99.6 (99.3–99.8) |
99.5 (99.1–99.7) |
99.1 (98.6–99.5) |
99.3 (98.9–99.6) |
Febrile by either ITDS or self-report | ||||
No. (%) identified as febrile by each method | 597 (23.8) | 586 (23.3) | 793 (38.5) | – |
Sensitivity (95% CI) | 93.8 (87.8–99.7) | 89.1 (81.4–96.7) | 93.8 (87.8–99.7) | – |
Specificity (95% CI) | 78.0 (76.4–79.5) | 78.4 (76.9–80.0) | 63.3 (61.6–65.1) | – |
Positive predictive value (95% CI) | 9.0 (6.9–11.2) | 8.8 (6.8–11.3) | 5.6 (4.3–7.1) | – |
Negative predictive value (95% CI) | 99.8 (99.5–99.9) | 99.7 (99.3–99.9) | 99.8 (99.4–99.9) | – |
*OptoTherm Thermoscreen (OptoTherm Thermal Imaging Systems and Infrared Cameras Inc., Sewickley, PA, USA), FLIR ThermoVision A20M (FLIR Systems Inc., Boston, MA, USA), and Wahl Fever Alert Imager HIS2000S (Wahl Instruments Inc., Asheville, NC, USA). CI, confidence interval; ITDS, infrared thermal detection system.
Page created: March 08, 2011
Page updated: March 08, 2011
Page reviewed: March 08, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.